<DOC>
	<DOCNO>NCT00004686</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare long term outcomes patient giant cell arteritis glucocorticoid treatment without methotrexate . II . Compare remission relapse rate patient glucocorticoid therapy without methotrexate . III . Determine whether adjunctive use methotrexate lower cumulative dose duration glucocorticoid therapy whether less treatment related morbidity mortality . IV . Demonstrate feasibility long term , double blind , placebo control , randomize , multicenter trial treatment systemic vasculitides .</brief_summary>
	<brief_title>Phase II Randomized Study Glucocorticoids With Without Methotrexate Treatment Giant Cell Arteritis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , multicenter study . Patients randomized initial therapy prednisone plus weekly placebo prednisone plus weekly oral methotrexate . Patients respond treatment within 5 day take study . If methotrexate toxicity dose occur 2 week , methotrexate increase one tablet per week maximum tolerate dose ( MTD ) achieve . The MTD methotrexate match placebo dose continue 12 month absence toxicity . Once 12 continuous month remission achieve , methotrexate placebo tapered discontinuation . Patients follow 1-6 year . Completion date provide represent completion date grant per OOPD record</detailed_description>
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis giant cell arteritis ( GCA ) least one following : Temporal artery biopsy confirm GCA Symptoms GCA ( include new onset ( within 6 month ) symptom headache , tenderness scalp temporal artery , visual loss due retinal ischemic optic neuropathy otherwise unexplained tongue jaw pain ) aortic angiogram reveal stenotic and/or aneurysmal disease aorta principal branch Symptoms polymyalgia rheumatica plus ischemic optic neuropathy , newly identify tenderness temporal artery , new onset tongue jaw pain Westergren erythrocyte sedimentation rate least 40 nm one hour Prior/Concurrent Therapy Endocrine therapy : No great 20 day since initiation prednisone therapy Other : No concurrent sulfa drug nonsteroidal antiinflammatory drug Patient Characteristics Hematopoietic : WBC least 4,000/mm3 Platelet count least 120,000/mm3 No acute chronic liver disease Hepatic : Alkaline phosphatase great 2 time upper limit normal No reproducible abnormal liver function test Renal : Creatinine le 2.0 mg/dL Other : HIV negative No symptomatic peptic ulcer disease within last 3 month Hepatitis B C antigen negative No alcohol use excess 2 ounce 100 proof liquor 1 beer equivalent per week No insulin dependent diabetes mellitus plus morbid obesity ( great 33 % ideal body weight ) No recently ( less 6 month ) diagnose malignancy Not pregnant nursing Adequate contraception require fertile patient</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>cardiovascular respiratory disease</keyword>
	<keyword>giant cell arteritis</keyword>
	<keyword>rare disease</keyword>
</DOC>